|
OMIM |
Link |
Information gain |
01 |
|
AFP
|
[NCBI]
|
0.00332441
|
|
|
myeloproliferative syndrome, transient
|
[NCBI]
|
0.00240255
|
|
|
hepatic fibrosis, severe, susceptibility to, due to schistosoma mansoni infection
|
[NCBI]
|
0.00211553
|
|
|
cirrhosis, familial
|
[NCBI]
|
0.00145719
|
|
|
renal-hepatic-pancreatic dysplasia with dandy-walker cyst
|
[NCBI]
|
0.000697531
|
|
|
cholestasis-lymphedema syndrome
|
[NCBI]
|
0.000626524
|
|
|
schistosoma mansoni infection, susceptibility/resistance to
|
[NCBI]
|
0.000600386
|
|
|
arima syndrome
|
[NCBI]
|
0.000578037
|
|
|
geleophysic dysplasia
|
[NCBI]
|
0.000541204
|
|
|
short rib-polydactyly syndrome, type iv
|
[NCBI]
|
0.000498592
|
|
|
PI
|
[NCBI]
|
0.000444534
|
|
|
ARPKD
|
[NCBI]
|
0.000386761
|
|
|
NPPA
|
[NCBI]
|
0.000338892
|
|
|
coach syndrome
|
[NCBI]
|
0.000279055
|
|
|
NAIC
|
[NCBI]
|
0.000248149
|
|
|
ALB
|
[NCBI]
|
0.000245719
|
|
|
HGF
|
[NCBI]
|
0.000234376
|
|
|
CTGF
|
[NCBI]
|
0.000230326
|
|
|
PFIC1
|
[NCBI]
|
0.000220016
|
|
|
ZS
|
[NCBI]
|
0.000192263
|
|
|
alpers diffuse degeneration of cerebral gray matter with hepatic cirrhosis
|
[NCBI]
|
0.000187415
|
|
|
glycogen storage disease iv
|
[NCBI]
|
0.000158059
|
|
|
hepatocellular carcinoma
|
[NCBI]
|
0.000156405
|
|
|
HFE
|
[NCBI]
|
0.000149726
|
|
|
australia antigen
|
[NCBI]
|
0.000148398
|
|
|
wilson disease
|
[NCBI]
|
0.000144348
|
|
|
AVP
|
[NCBI]
|
0.000134752
|
|
|
sea-blue histiocyte disease
|
[NCBI]
|
0.000125884
|
|
|
MKS1
|
[NCBI]
|
0.000123803
|
|
|
ZNF267
|
[NCBI]
|
0.000107742
|
|
|
transaldolase deficiency
|
[NCBI]
|
0.000105045
|
|
|
liver fibrocystic disease and polydactyly
|
[NCBI]
|
0.000105045
|
|
|
HHT
|
[NCBI]
|
0.000103363
|
|
|
gilbert syndrome
|
[NCBI]
|
0.000102058
|
|
|
KLK3
|
[NCBI]
|
9.91595e-05
|
|
|
tyrosinemia, type i
|
[NCBI]
|
9.53968e-05
|
|
|
LHX2
|
[NCBI]
|
8.88039e-05
|
|
|
RA
|
[NCBI]
|
8.72347e-05
|
|
|
glycogen storage disease iii
|
[NCBI]
|
8.67489e-05
|
|
|
CDG1A
|
[NCBI]
|
7.59111e-05
|
|
|
PCNA
|
[NCBI]
|
7.46438e-05
|
|
|
cirrhosis, familial
|
[NCBI]
|
7.41399e-05
|
|
|
PTH
|
[NCBI]
|
7.40147e-05
|
|
|
adrenoleukodystrophy, autosomal neonatal form
|
[NCBI]
|
7.34142e-05
|
|
|
PHKG2
|
[NCBI]
|
6.99539e-05
|
|
|
polycystic kidneys
|
[NCBI]
|
6.96643e-05
|
|
|
ABL
|
[NCBI]
|
6.89712e-05
|
|
|
IFNA1
|
[NCBI]
|
6.46299e-05
|
|
|
bile acid synthesis defect, congenital, 1
|
[NCBI]
|
6.45852e-05
|
|
|
renal dysplasia, retinal pigmentary dystrophy, cerebellar ataxia, and skeletal dysplasia
|
[NCBI]
|
6.45852e-05
|
|
|
HRG
|
[NCBI]
|
6.39414e-05
|
|
|
EGF
|
[NCBI]
|
6.17111e-05
|
|
|
KRT8
|
[NCBI]
|
6.06597e-05
|
|
|
EGFR
|
[NCBI]
|
5.73816e-05
|
|
|
hyperpipecolatemia
|
[NCBI]
|
5.63574e-05
|
|
|
LGALS3
|
[NCBI]
|
5.4436e-05
|
|
|
NPHP3
|
[NCBI]
|
5.43505e-05
|
|
|
CIRH1A
|
[NCBI]
|
5.38633e-05
|
|
|
RNPC2
|
[NCBI]
|
5.38633e-05
|
|
|
CDG1B
|
[NCBI]
|
5.25704e-05
|
|
|
HFE4
|
[NCBI]
|
5.25704e-05
|
|
|
C5
|
[NCBI]
|
5.11951e-05
|
|
|
iron overload in africa
|
[NCBI]
|
5.09714e-05
|
|
|
gaucher disease, perinatal lethal
|
[NCBI]
|
5.09714e-05
|
|
|
crigler-najjar syndrome, type ii
|
[NCBI]
|
4.95205e-05
|
|
|
AR
|
[NCBI]
|
4.91249e-05
|
|
|
PKHD1
|
[NCBI]
|
4.84333e-05
|
|
|
hepatitis c virus, susceptibility to
|
[NCBI]
|
4.81928e-05
|
|
|
BBS
|
[NCBI]
|
4.63098e-05
|
|
|
CDS
|
[NCBI]
|
4.58353e-05
|
|
|
HGFAC
|
[NCBI]
|
4.39043e-05
|
|
|
RTD
|
[NCBI]
|
4.03692e-05
|
|
|
STMN2
|
[NCBI]
|
4.01267e-05
|
|
|
CXCR6
|
[NCBI]
|
4.01267e-05
|
|
|
CSRP2
|
[NCBI]
|
4.01267e-05
|
|
|
TALDO1
|
[NCBI]
|
4.01267e-05
|
|
|
BCL9
|
[NCBI]
|
4.01267e-05
|
|
|
PLG
|
[NCBI]
|
3.97683e-05
|
|
|
SLSN1
|
[NCBI]
|
3.89094e-05
|
|
|
IGFALS
|
[NCBI]
|
3.78511e-05
|
|
|
SLE
|
[NCBI]
|
3.66886e-05
|
|
|
CRH
|
[NCBI]
|
3.56954e-05
|
|
|
NGFB
|
[NCBI]
|
3.55764e-05
|
|
|
FCGRT
|
[NCBI]
|
3.49694e-05
|
|
|
BMP3
|
[NCBI]
|
3.49694e-05
|
|
|
IL32
|
[NCBI]
|
3.49694e-05
|
|
|
TEP1
|
[NCBI]
|
3.16357e-05
|
|
|
KRT18
|
[NCBI]
|
3.16357e-05
|
|
|
IL13RA2
|
[NCBI]
|
3.16357e-05
|
|
|
ACHE
|
[NCBI]
|
2.97687e-05
|
|
|
CF
|
[NCBI]
|
2.92879e-05
|
|
|
IGF2BP2
|
[NCBI]
|
2.91681e-05
|
|
|
PCTT
|
[NCBI]
|
2.87425e-05
|
|
|
NPHP3
|
[NCBI]
|
2.72107e-05
|
|
|
PRL
|
[NCBI]
|
2.66449e-05
|
|
|
galactosemia
|
[NCBI]
|
2.59172e-05
|
|
|
protoporphyria, erythropoietic
|
[NCBI]
|
2.56764e-05
|
|
|
PROK1
|
[NCBI]
|
2.55903e-05
|
|
|
APOE
|
[NCBI]
|
2.49947e-05
|
|
|
CYGB
|
[NCBI]
|
2.42094e-05
|
|
|
GFER
|
[NCBI]
|
2.42094e-05
|
|
|
PIAS1
|
[NCBI]
|
2.42094e-05
|
|
|
MPO
|
[NCBI]
|
2.37728e-05
|
|
|
CFTR
|
[NCBI]
|
2.31845e-05
|
|
|
C5R1
|
[NCBI]
|
2.30077e-05
|
|
|
NOV
|
[NCBI]
|
2.30077e-05
|
|
|
CYP2A6
|
[NCBI]
|
2.30077e-05
|
|
|
SHBG
|
[NCBI]
|
2.28966e-05
|
|
|
MPI
|
[NCBI]
|
2.19451e-05
|
|
|
ALGS1
|
[NCBI]
|
2.17915e-05
|
|
|
GFAP
|
[NCBI]
|
2.14002e-05
|
|
|
CPB2
|
[NCBI]
|
2.12112e-05
|
|
|
TG
|
[NCBI]
|
2.11414e-05
|
|
|
NPC1
|
[NCBI]
|
2.07894e-05
|
|
|
LPI
|
[NCBI]
|
2.04096e-05
|
|
|
CEACAM5
|
[NCBI]
|
2.00731e-05
|
|
|
gaucher disease, type i
|
[NCBI]
|
2.00408e-05
|
|
|
ABCB4
|
[NCBI]
|
1.93474e-05
|
|
|
ASL
|
[NCBI]
|
1.93474e-05
|
|
|
FLT1
|
[NCBI]
|
1.86262e-05
|
|
|
MTP
|
[NCBI]
|
1.86262e-05
|
|
|
FGFR4
|
[NCBI]
|
1.86262e-05
|
|
|
SDS
|
[NCBI]
|
1.80326e-05
|
|
|
RIPK1
|
[NCBI]
|
1.6763e-05
|
|
|
IFNGR1
|
[NCBI]
|
1.6763e-05
|
|
|
TH
|
[NCBI]
|
1.60161e-05
|
|
|
KLF6
|
[NCBI]
|
1.57137e-05
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
1.50726e-05
|
|
|
RBP4
|
[NCBI]
|
1.47813e-05
|
|
|
SFRP1
|
[NCBI]
|
1.43519e-05
|
|
|
NPY
|
[NCBI]
|
1.42249e-05
|
|
|
SERPINA6
|
[NCBI]
|
1.41435e-05
|
|
|
CDKN1A
|
[NCBI]
|
1.39441e-05
|
|
|
SOCS1
|
[NCBI]
|
1.39441e-05
|
|
|
NR0B2
|
[NCBI]
|
1.39441e-05
|
|
|
LPL
|
[NCBI]
|
1.36316e-05
|
|
|
DNMT1
|
[NCBI]
|
1.35551e-05
|
|
|
TYMS
|
[NCBI]
|
1.34872e-05
|
|
|
VHL
|
[NCBI]
|
1.32927e-05
|
|
|
TNF
|
[NCBI]
|
1.3234e-05
|
|
|
SMPD1
|
[NCBI]
|
1.28321e-05
|
|
|
CDK4
|
[NCBI]
|
1.27251e-05
|
|
|
ADA
|
[NCBI]
|
1.26054e-05
|
|
|
ABP1
|
[NCBI]
|
1.25925e-05
|
|
|
ENPP2
|
[NCBI]
|
1.24938e-05
|
|
|
SPARC
|
[NCBI]
|
1.21697e-05
|
|
|
MBL2
|
[NCBI]
|
1.17573e-05
|
|
|
GHR
|
[NCBI]
|
1.15853e-05
|
|
|
GPC3
|
[NCBI]
|
1.12728e-05
|
|
|
CTSC
|
[NCBI]
|
1.12728e-05
|
|
|
SOCS3
|
[NCBI]
|
1.09962e-05
|
|
|
REN
|
[NCBI]
|
1.09962e-05
|
|
|
CCK
|
[NCBI]
|
1.07157e-05
|
|
|
GC
|
[NCBI]
|
1.04725e-05
|
|
|
PROCR
|
[NCBI]
|
9.98437e-06
|
|
|
apnea, obstructive sleep
|
[NCBI]
|
9.77806e-06
|
|
|
PRLR
|
[NCBI]
|
9.75236e-06
|
|
|
F2R
|
[NCBI]
|
9.31033e-06
|
|
|
VCP
|
[NCBI]
|
9.09957e-06
|
|
|
RBP1
|
[NCBI]
|
8.69685e-06
|
|
|
DBI
|
[NCBI]
|
8.31725e-06
|
|
|
wolman disease
|
[NCBI]
|
8.31725e-06
|
|
|
MTAP
|
[NCBI]
|
8.13546e-06
|
|
|
ADM
|
[NCBI]
|
7.91302e-06
|
|
|
DMPK
|
[NCBI]
|
7.78673e-06
|
|
|
MMP9
|
[NCBI]
|
7.61936e-06
|
|
|
AQP2
|
[NCBI]
|
7.4564e-06
|
|
|
TLR9
|
[NCBI]
|
7.143e-06
|
|
|
HBB
|
[NCBI]
|
7.11474e-06
|
|
|
TGFB1
|
[NCBI]
|
6.70179e-06
|
|
|
LIPC
|
[NCBI]
|
6.70179e-06
|
|
|
GPT
|
[NCBI]
|
6.70179e-06
|
|
|
PKD2
|
[NCBI]
|
6.42526e-06
|
|
|
glycogen storage disease i
|
[NCBI]
|
6.0344e-06
|
|
|
IDE
|
[NCBI]
|
5.91006e-06
|
|
|
CD
|
[NCBI]
|
5.7893e-06
|
|
|
porphyria cutanea tarda
|
[NCBI]
|
5.78854e-06
|
|
|
PTN
|
[NCBI]
|
5.66972e-06
|
|
|
STAT1
|
[NCBI]
|
5.55354e-06
|
|
|
MTR
|
[NCBI]
|
5.32874e-06
|
|
|
LBP
|
[NCBI]
|
5.21996e-06
|
|
|
EPO
|
[NCBI]
|
5.18063e-06
|
|
|
ASS
|
[NCBI]
|
4.80734e-06
|
|
|
XDH
|
[NCBI]
|
3.23543e-06
|
|
|
CVID
|
[NCBI]
|
2.72009e-06
|
|
|
PON1
|
[NCBI]
|
2.45576e-06
|
|
|
TFPI
|
[NCBI]
|
2.03146e-06
|
|
|
LRP1
|
[NCBI]
|
1.55134e-06
|
|
|
ACPP
|
[NCBI]
|
1.51269e-06
|
|
|
COMT
|
[NCBI]
|
1.49516e-06
|
|
|
von willebrand disease
|
[NCBI]
|
1.4774e-06
|
|
|
TNFSF6
|
[NCBI]
|
1.47159e-06
|
|
|
HMBS
|
[NCBI]
|
1.44141e-06
|
|
|
CAT
|
[NCBI]
|
1.28616e-06
|
|
|
PF4
|
[NCBI]
|
1.16026e-06
|
|
|
TNFRSF11B
|
[NCBI]
|
1.10019e-06
|
|
|
GAPDH
|
[NCBI]
|
8.15353e-07
|
|
|
SDC2
|
[NCBI]
|
7.26897e-07
|
|
|
SLC6A3
|
[NCBI]
|
7.06521e-07
|
|
|
PEDF
|
[NCBI]
|
6.20803e-07
|
|
|
HP
|
[NCBI]
|
6.1638e-07
|
|
|
SPINK1
|
[NCBI]
|
6.00857e-07
|
|
|
PPARA
|
[NCBI]
|
5.1104e-07
|
|
|
AHR
|
[NCBI]
|
4.96289e-07
|
|
|
APOB
|
[NCBI]
|
4.56843e-07
|
|
|
OSM
|
[NCBI]
|
4.39246e-07
|
|
|
GJA1
|
[NCBI]
|
3.92163e-07
|
|
|
IL2
|
[NCBI]
|
3.76724e-07
|
|
|
IAPP
|
[NCBI]
|
3.20728e-07
|
|
|
F3
|
[NCBI]
|
3.04651e-07
|
|
|
SOD2
|
[NCBI]
|
3.01236e-07
|
|
|
TF
|
[NCBI]
|
2.92617e-07
|
|
|
GPI
|
[NCBI]
|
2.81913e-07
|
|
|
COMP
|
[NCBI]
|
1.46106e-07
|
|
|
VEGF
|
[NCBI]
|
1.39046e-07
|
|
|
SPP1
|
[NCBI]
|
1.30705e-07
|
|
|
GIP
|
[NCBI]
|
1.19411e-07
|
|
|
PYY
|
[NCBI]
|
8.02583e-08
|
|
|
VIP
|
[NCBI]
|
5.63361e-08
|
|
|
STAT3
|
[NCBI]
|
1.12081e-09
|
|
|
GHRH
|
[NCBI]
|
5.50892e-10
|
|
|
FGF7
|
[NCBI]
|
1.82075e-10
|
|
|
CP
|
[NCBI]
|
1.25715e-11
|
|